Explore the latest studies, experimental protocols, and scientific breakthroughs in apoptosis mechanisms
Discover how combining FLT-3 inhibitors with HSP90 blockers creates a synergistic therapy that effectively targets acute myelogenous leukemia with mutant FLT-3.